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ABSTRACT
Guinea pigs sensitized to a purified preparation of lepromin Were treated with metho-
trexate, either during induction or after sensitization had heen established. This drug had
no detectable effect on established hypersensitivity to lepromin or upon the development
of non-specific granulomatous inflammation produced by incomplete Freund's adjuvant.
But it blocked the induction of the granulomatous response to lepromin (Mitsuda reac-
tion). These findings add a facet to the evidence that this reactivity represents a type of
hypersensitivity to Mycobacteriuni lepree.
Crude (Whole) lepromin is an intradermal
diagnostic agent prepared by grinding heated
lepromata rich in bacilli, and suspending this
in phenol-saline. The intradermal injection of
this "antigen" may induce the formation of a
granuloma. This is evaluated in clinical practice
three to four weeks after injection (Mitsuda
reaction).
The nature of this granulomatous response
is open to question in several respects. Which
component of lepromin (bacilli or dermal
tissue) induces the reaction (1, 2, 3)? Is this
reaction immunologic in nature?
In the course of studies of reactions in
guinea pigs to a purified lepromin preparation,
we have demonstrated that the major response
occurs to the bacillary component (4) that
animals sensitized by a variety of pathogenic
or saprophytic myeobaeteria subsequently re-
act specifically to the intradermal injection of
lepromin with the formation of granuloma
(5), and that reactivity to lepromin is of de-
layed hypersensitive kind as judged by pas-
sive transfer to normal animals by viable
lymphoid cells but not by heat-killed cells or
serum (6, 7).
In order to characterize this reactivity fur-
ther, a study was made of the influence of
4-amino-4 deoxy-N10-methyl folie acid (metho-
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trexate) upon the process of induction of hy-
persensitivity as well as in established reac-
tivity to lepromin. It is known that this drug,
or its analog aminopterin, suppresses the dis-
seminated lesions of adjuvant disease in the
rat (5), inhibits the development of contact
sensitivity (9), and of hypersensitivity to
tuberculin (10), as well as the occurrence of
easeation necrosis in experimental tuberculosis
(11), and prolongs the survival of homografts
(12, 13).
MATERIALS AND METHODS
Lepromin was prepared as a purified suspension
of Mycobacterium leprac by sequential enzymatic
digestion of ground epidermis-free tissue (6, 7) .
Two concentrations were used. "Strong lepromin"
contained approximately 430 X 10° bacilli per ml.
"Test lepromin" contained about 143 >< 10° bacilli
per ml. The latter preparation was used intrader-
mally in lepromatous and tuberculoid patients, in
clinically healthy contacts of these eases, and in
BCG immunized subjects. It induced Mitsuda re-
actions in appropriate subjects equivalent to those
expected from crude lepromin.
Dermis suspension was prepared from ground
normal human dermis by the methods used for
snaking lepromin. Methotrexate was kindly sup-
plied by Dr. Hugh McDonald of the Medical Re-
search Section, Lederle Laboratories, Pearl River,
New York. Incomplete Freund's adjuvant was
purchased from Difco Laboratories.
Four hundred to 500 gram male albino random-
bred guinea pigs were used. They were kept in
isolation under the care of a special attendant
employing gowns and hand and shoe disinfection
procedures. Animals were fed Purina guinea pig
pellets, water ad libitum and carrots three times
a week. During methotrexate administration car-
rots were discontinued to eliminate folic acid in-
take, and the animals received instead ascorbic
t Fresh lepromata were, supplied by Dr.
Jacinto Convit, Head, División de DermatologIa
Sanitaria. M .S.A .S., Caracas, Venezuela.
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acid in their drinking water, 12 grams per gallon
of water.
EXPERIMENTS
1. The influence of methotrexate upon
established hypersensitivity to
lepromin
Nineteen guinea pigs were sensitized with
"strong lepromin" emulsified in incomplete
Fio. 1. Overall structure and results of Experiments 1 and 2
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FIG. 2. Reactions to "test" lepromin, direct readings (Experiment 1). Values shown are
the arithmetic means of diameters of induration (in mm) of sites injected with test lepromin,
EXPERIMENT I
Freund's adjuvant, injected into all foot pads
and subcutaneously in the neck for a total of
0.5 ml per animal. Six weeks later they re-
ceived two simultaneous intradermal injections
of 0.1 ml each of "test lepromin" and this
was repeated 4 weeks later. After 4 more weeks
these animals and 6 untreated controls were
injected intradermally with 0.1 ml amounts of
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"test lepromin", of an equivalent concentration
of normal human dermis suspension, and of
incomplete Freund's adjuvant.
Beginning at two days before these intrader-
mal injections, and continuing on the day of
the injections and three times weekly there-
after, 12 of the sensitized animals were treated
with methotrexate freshly dissolved in 0.5%
sodium bicarbonate and given intraperitoneally,
20 mg per kg of weight. Diameters of indura-
tion of skin injection sites were determined at
4 hours and at 1, 2, 5, 8, 10, 15, 18, 21, and
23 days. Lepromin readings were recorded as
direct and as corrected readings; the latter
represent the difference between readings of
sites injected with lepromin and of those in-.
jected with dermis suspension. At 23 days
representative sites were biopsied, fixed in
buffered formalin pH 7.4 and stained by the
hematoxylin-eosin, methyl green pyronin,
Giemsa and Ziehi-Neelsen methods.
Results. The overall structure and results
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of the experiment are shown in Figure 1 (Ex-
periment 1). As seen in Figures 2 and 3, sensi-
tized animals treated with methotrexate
showed considerably larger reactions to lepro-
mm than did the non-sensitized controls.
The results in the drug-treated, sensitized
group were comparable to those observed in
previous experiments in which guinea pigs had
been sensitized to lepromin by the same pro-
cedure.
Methotrexate had no detectable effect upon
the intensity of the granulomatous response
induced by the intradermal injection of in-
complete adjuvant, which was comparable in
all groups.
Histologically, positive reactors to lepromin
showed a confluent granulornatous infiltrate in
the dermis-subcutaneous junction and deep
dermis. The infiltrate was rather disperse and
was composed mainly of macrophages in the
superficial dermis.
——-a-——— Sensitized to lepromin treated with methotrexate
——0——— Sensitized to lepromin not treated with methotrexate
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FIG. 3. Reactions to "test" lepromin, corrected readings (Experiment 1). Values shown
are the arithmetic means of the difference between diameter of induration (in mm) of the
site injected with test lepromin and the site injected with equivalent dermis suspension.
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2. Effect of methotrexate during the
induction of hypersensitivity
to lepromin
The overall structure and results of this
experiment are shown in Figure 1 (Experiment
2). In order to avoid the possible effect of ad-
juvant in overcoming suppression, as well as
to minimize continuing stimulation of lymph
nodes draining sites of antigen injection after
cessation of treatment with methotrexate, the
following procedure for sensitization was used.
Eighteen guinea pigs received two simultaneous
intradermal injections of 0.1 ml each of
"strong lepromin." After two weeks the in-
jected sites were widely excised. This was re-
peated three weeks later, and six weeks after
this the animals were tested with 0.1 ml of
"test lepromin" intradermally to determine
whether sensitization had occurred in non-
drug treated animals. These sites also were
excised. One month later animals were given
final tests with 0.1 ml each of test lepromin,
equivalent dermis suspension, and incomplete
Freund's adjuvant, in separate sites. Reactions
were evaluated and sites biopsied as described
for the first experiment.
Of the 18 animals, 12 ("blocked" animals)
were treated with methotrexate, 20 mg per kg
intraperitoneally, beginning two days before
each series of sensitizing injections and re-
peated on the day of injection and three times
weekly thereafter, until the sites were excised.
At this time the drug was discontinued, to be
reinitiated in the same fashion with each
sensitizing injection. During the last test pe-
riod, treatment was continued for 18 days in
6 of these animals, while the remaining 6 were
not treated.
Results. The non-drug-treated animals be-
came sensitive to lepromin. Their reactions
were grossly and histologically comparable to
those seen in sensitized animals of previous
experiments (6, 14) and in Experiment 1.
The two subgroups of drug-treated animals,
those that received methotrexate during the
induction period only, and those that continued
to receive it during the test period, were
pooled for assessment of their reaetivities, since
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Fcc. 4. Reactions to "test" leprornin, direct readings (Experiments 1 and 2). (See legend
of Figure 1.)
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there was no appreciable statistical difference
between their reactions. The drug-treated ani-
mals showed significantly lower readings ( P <
0.01 after 24 hours by t-test) than the sensi-
tized controls. These "blocked" animals had
slightly greater inflammatory reactions to
lepromin than non-sensitized controls, but
these differences were not statistically signifi-
cant. Salient features of these results are shown
iii Figures 4 and 5.
As in the first experiment, the intensity of
the granulomatous response produced by in-
complete Freund's adjuvant was similar in all
groups.
DIscussIoN
These results indicate that an immunosup-
pressant drug (methotrexate) influences re-
sponsiveness to lepromin in a manner similar
to that seen in the development of other hy-
persensitive reactivities. The drug affects the
induction of the reactivity which leads to
granuloma formation on exposure to lepromin,
but has no detectable effect upon the reactive
state once established.
It is of interest that the inhibition of re-
activity was relatively long lived, persisting
even after the drug was discontinued. This
contrasts with what has been reported in
developing contact sensitivity (9) and some-
what indirectly, in relation to tuberculin hy-
persensitivity (10).
The effect of methotrexate is attributable to
its immunosuppressive action rather than to
a non-specific anti-inflammatory effect as sug-
gested by Hersh (15), since the drug failed
to affect established sensitivity and had no
detectable influence upon the development of a
non-specific granuloma induced by incomplete
Freund's adjuvant.
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